Key result
NOS2-deficient MRL-lpr/lpr mice developed similar glomerular and synovial pathology to wildtype mice, but had significantly less vasculitis of medium-sized renal vessels and lower IgG rheumatoid factor.
Targeted disruption of NOS2 in MRL-lpr/lpr mice reduces renal vasculitis and IgG rheumatoid factor levels but does not affect glomerular or synovial pathology, indicating heterogeneity in disease mechanisms.
Answers are grounded in this paper and cite their sources.
Indicates heterogeneous NOS2 dependence across lupus manifestations; hypothesis-generating for selective targeting and leaves open validation in other models.
Nitric oxide (NO) is an important mediator of the inflammatory response. MRL-lpr/lpr mice overexpress inducible nitric oxide synthase (NOS2) and overproduce NO in parallel with the development of an autoimmune syndrome with a variety of inflammatory manifestations. In previous studies, we showed that inhibiting NO production with the nonselective nitric oxide synthase (NOS) inhibitor NG-monomethyl-arginine reduced glomerulonephritis, arthritis, and vasculitis in MRL-lpr/lpr mice. To define further the role of NO and NOS2 in disease in MRL-lpr/lpr mice, mice with targeted disruption of NOS2 were produced by homologous recombination and bred to MRL-lpr/lpr mice to the N4 generation. MRL-lpr/lpr littermates homozygous for disrupted NOS2 (-/-), heterozygous for disrupted NOS2 (+/-), or wildtype (+/+) were derived for this study. Measures of NO production were markedly decreased in the MRL-lpr/lpr (-/-) mice compared with MRL-lpr/lpr (+/+) mice, with intermediate production by the MRL-lpr/lpr (+/-) mice. There was no detectable NOS2 protein by immunoblot analysis of the spleen, liver, kidney, and peritoneal macrophages of the (-/-) animals, whereas that of (+/+) was high and (+/-) intermediate. The (-/-) mice developed glomerular and synovial pathology similar to that of the (+/-) and (+/+) mice. However, (-/-) mice and (+/-) mice had significantly less vasculitis of medium-sized renal vessels than (+/+) mice. IgG rheumatoid factor levels were significantly lower in the (-/-) mice as compared with (+/+) mice, but levels of anti-DNA antibodies were comparable in all groups. Our findings show that NO derived from NOS2 has a variable impact on disease manifestations in MRL-lpr/lpr mice, suggesting heterogeneity in disease mechanisms.
No takes yet. Share an insight, caveat, or question.
Gilkeson et al. (1997) studied Autoimmune syndrome. Targeted disruption of NOS2 vs. Wildtype (+/+) MRL-lpr/lpr mice was evaluated on Glomerular and synovial pathology, vasculitis, and autoantibody levels. NOS2-deficient MRL-lpr/lpr mice developed similar glomerular and synovial pathology to wildtype mice, but had significantly less vasculitis of medium-sized renal vessels and lower IgG rheumatoid factor.
Synapse has enriched 10 related papers. Consider them for comparative context: